Stage at diagnosis of prostate cancer in Connecticut by poverty and race

Ethnicity and Disease

Volumn 7, Issue 3, 1997, Pages 215-220

  Polednak, Anthony P ^a  

^a Connecticut Dept of Public Health ^*  (United States)

Author keywords

African Americans; Blacks; Prostate carcinoma

Indexed keywords

AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; ATTITUDE TO HEALTH; CANCER STAGING; CASE REPORT; CAUCASIAN; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; ETHNOLOGY; HUMAN; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; NEGRO; PATHOLOGY; POVERTY; PROSTATE TUMOR; REGISTER; SEX RATIO; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS; UNITED STATES;

AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CHI-SQUARE DISTRIBUTION; CONNECTICUT; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; POVERTY; PROSTATIC NEOPLASMS; REGISTRIES; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS;

EID: 0031217873     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1992: Tables and Graphs. Bethesda, Md: National Cancer Institute; 1995. NIH Publication No. 96-2789.
2. Miller BA, Kolonel LN, Bernstein L, et al., eds. Racial/Ethnic Patterns of Cancer in the United States 1988-1992. Bethesda, Md: National Cancer Institute; 1996. NIH Publication 96-4104.
3. Baquet CR, Horm JW, Gibbs T, Greenwald P. Socioeconomic factors and cancer incidence among blacks and whites. JNCI. 1991;83:51-557.
4. Blustein J. The reliability of racial classifications in hospital discharge abstract data. Am J Public Health. 1994; 84:1018-1021.
5. Shambaugh E. Stat bite: Accuracy of SEER data. JNCI. 1991; 83:1369.
6. Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the NCI. Cancer. 1995;76:2343-2350.
7. Polednak AP, Flannery JT. Black versus white racial differences in clinical stage at diagnosis and treatment of prostate cancer in Connecticut. Cancer. 1992;70:2152-2158.
8. Lu-Yao GL, Greenberg ER. Changes in prostate cancer incidence and treatment in USA. Lancet. 1994;343:251-264.
9. Shambaugh EM, Ries LAG, Young JJL, Kruse MA. SEER extent of disease 1988 codes and coding instructions. Rockville, Md: National Cancer Institute, 1988.
10. Krieger N. Overcoming the absence of socioeconomic data in medical records; Validation and application of a census-based methodology. Am J Public Health. 1992;92:703-710.
11. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics. 1955;11:375-386.
12. Liu WL, Kasl S, Flannery JT, Londo A, Dubrow R. The accuracy of prostate cancer staging in a population-based tumor registry and its impact on the black-white stage difference (Connecticut, United States). Cancer Causes Cont. 1995;6:425-430.
13. Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. JNCI. 1995;87:1686-1693.
14. Schruvers CTM, Mackenbach JP, Lutz JM, Quinn MJ, Coleman MP. Deprivation, stage at diagnosis and cancer survival. Int J Cancer. 1995;63:324-329.
15. Brawer MK. Predictive value of prostate cancer tests. JNCI. 1993;85:695.
16. American Medical Association. Black-white disparities in health care. JAMA. 1990;263:2344-2346.
17. Gelfand DE, Parzuchowski J, Cort M, Powell I. Digital rectal examinations and prostate cancer screening: Attitudes of African American men. Oncol Nurs. 1995;22:1253-1255.
18. Centers for Disease Control. Provisional estimates from the National Health Interview Survey Supplement on Cancer Control - United States, January-March 1987. MMWR. 1988;37:417-425.
19. Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein CR, Kramer B. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA. 1995;274:1599-1605.
20. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995;273: 548-552.
21. Whittemore AS, Keller JB, Betensky R. Low-grade, latent prostate cancer volume: Predictor of clinical cancer incidence? JNCI. 1991;83:1231-1235.
22. Hsing AW. Hormones and prostate cancer: Where do we go from here? JNCI. 1996;88:1093-1095.
23. Wu AH, Whittemore AS, Kolonel LN, et al. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev. 1995;4:735-741.
24. Kolonel LN. Nutrition and prostate cancer. Cancer Causes Cont. 1996;7:83-94.
25. Ross RK, Coetzee GA, Reichardt J, Skinner E, Henderson BE. Does the racial-ethnic variation in prostate cancer risk have a hormonal basis? Cancer. 1995;75:1778-1782.
26. Waxman J, Sheer D. Is prostate cancer worth diagnosing? Lancet. 1995;346:1177-1178.
27. Feldman D. Androgen and vitamin D receptor gene poly-morphisms: The long and short of prostate cancer risk. JNCI. 1997;89:109-111.